Found 80 matching trials
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
PHASE1The purpose of this trial is to estimate the recommended dose (RD) of \[177...
Status
Active Not Recruiting
Location
UCLA Jonsson Comp Cancer Center
Reducing Postoperative Catheterization
NAAfter reconstructive pelvic surgery urinary retention occurs in up to 60% o...
Location
University of North Carolina at Chapel Hill
A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors
PHASE1This is a Phase 1 study to assess the safety and clinical activity of RO762...
Location
University of California Irvine Medical Center
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
PHASE1The overall goal of this first-in-human (FIH) clinical trial is to learn ab...
Location
Yale- New Haven Hospital- Yale Cancer Center
Urinary Retention After Total Laparoscopic Hysterectomy With Immediate Foley Catheter Removal Versus Backfill Void Trial
NAAcute urinary retention is a complication of hysterectomies that can result...
Location
Cleveland Clinic Florida
Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive B-Cell Lymphoma
PHASE1This is a Phase I/II clinical study conducted in participants with relapsed...
Location
Multiple Locations
Assessment of Voiding After Sling
NAThe purpose of this study is to compare the incidence of catheterization fr...
Location
Cleveland Clinic Beachwood
XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors
PHASE1This is a first-in-human, multicenter, Phase 1/2, open-label study designed...
Location
Multiple Locations
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
PHASE1The purpose of this study is to determine the safety and tolerability of mo...
Location
Clinical Study Site
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
PHASE1This is a multicenter, open-label, Phase 1 study. The study will enroll sub...
Location
University of Colorado Hospital - Anschutz Cancer Pavilion